Scholarlink

<p>Hepatocellular carcinoma (HCC) remains a therapeutic challenge, necessitating novel treatment strategies. This study explored the antitumor activity and underlying mechanisms of NK4 overexpression in HCC. Utilizing engineered NK4-overexpressing HepG2 cells and a TPA-inducible TP-NK4 system evaluated in both HepG2 and MHCC97-H cells, we demonstrated that NK4 significantly inhibits HCC cell proliferation and migration <i>in vitro</i>. Furthermore, NK4 potently induced apoptotic cell death, as evidenced by the modulation of key regulators Bax and Bcl-2. Crucially, the induction of NK4 expression also promoted autophagy and attenuated tumor growth in a mouse xenograft model. Mechanistic analysis indicated that inhibition of the MAPK pathway is central to these anticancer effects. Our integrated findings establish NK4 as a potent multi-faceted inhibitor of HCC progression and highlight its strong therapeutic potential for precision oncology applications by targeting apoptosis, autophagy, and MAPK signaling.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Overexpression of NK4 suppresses hepatocellular carcinoma progression by inducing apoptosis and autophagy via MAPK pathway inhibition​

  • 期刊论文

  • 发表日期：

    2026年4月1日

查看全文
  • Shangdi Zhang,
  • Jinming Wang,
  • Shan Gao,
  • Caiyan Gao,
  • Linmei Chen,
  • Ping Qi

摘要

Hepatocellular carcinoma (HCC) remains a therapeutic challenge, necessitating novel treatment strategies. This study explored the antitumor activity and underlying mechanisms of NK4 overexpression in HCC. Utilizing engineered NK4-overexpressing HepG2 cells and a TPA-inducible TP-NK4 system evaluated in both HepG2 and MHCC97-H cells, we demonstrated that NK4 significantly inhibits HCC cell proliferation and migration in vitro. Furthermore, NK4 potently induced apoptotic cell death, as evidenced by the modulation of key regulators Bax and Bcl-2. Crucially, the induction of NK4 expression also promoted autophagy and attenuated tumor growth in a mouse xenograft model. Mechanistic analysis indicated that inhibition of the MAPK pathway is central to these anticancer effects. Our integrated findings establish NK4 as a potent multi-faceted inhibitor of HCC progression and highlight its strong therapeutic potential for precision oncology applications by targeting apoptosis, autophagy, and MAPK signaling.